
James Henry Alstrum Acevedo
Supervisory Patent Examiner (ID: 1021, Phone: (571)272-5548 , Office: P/1675 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1622, 1616, 1654, 1675 |
| Total Applications | 708 |
| Issued Applications | 222 |
| Pending Applications | 98 |
| Abandoned Applications | 392 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19656913
[patent_doc_number] => 20240423978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 18/635697
[patent_app_country] => US
[patent_app_date] => 2024-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18635697
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/635697 | EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL LUNG CANCER | Apr 14, 2024 | Abandoned |
Array
(
[id] => 19231395
[patent_doc_number] => 20240188585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => METHOD FOR PROVIDING PROTEINACEOUS COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/585703
[patent_app_country] => US
[patent_app_date] => 2024-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18585703
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/585703 | METHOD FOR PROVIDING PROTEINACEOUS COMPOSITION | Feb 22, 2024 | Pending |
Array
(
[id] => 19231395
[patent_doc_number] => 20240188585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => METHOD FOR PROVIDING PROTEINACEOUS COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/585703
[patent_app_country] => US
[patent_app_date] => 2024-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18585703
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/585703 | METHOD FOR PROVIDING PROTEINACEOUS COMPOSITION | Feb 22, 2024 | Pending |
Array
(
[id] => 20401185
[patent_doc_number] => 12491144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Toothpaste composition
[patent_app_type] => utility
[patent_app_number] => 18/128025
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7857
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128025
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128025 | Toothpaste composition | Mar 28, 2023 | Issued |
Array
(
[id] => 19477498
[patent_doc_number] => 20240325540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => METHOD OF ENHANCING HUMAN IMMUNITY THROUGH SOLID WATER PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/126672
[patent_app_country] => US
[patent_app_date] => 2023-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18126672
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/126672 | METHOD OF ENHANCING HUMAN IMMUNITY THROUGH SOLID WATER PARTICLES | Mar 26, 2023 | Pending |
Array
(
[id] => 20371176
[patent_doc_number] => 12478590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => In situ method of making porous 2D based tri-nanocomposite for use in medical treatment
[patent_app_type] => utility
[patent_app_number] => 18/085433
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 0
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085433
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/085433 | In situ method of making porous 2D based tri-nanocomposite for use in medical treatment | Dec 19, 2022 | Issued |
Array
(
[id] => 20371176
[patent_doc_number] => 12478590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => In situ method of making porous 2D based tri-nanocomposite for use in medical treatment
[patent_app_type] => utility
[patent_app_number] => 18/085433
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 0
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 276
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085433
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/085433 | In situ method of making porous 2D based tri-nanocomposite for use in medical treatment | Dec 19, 2022 | Issued |
Array
(
[id] => 17595779
[patent_doc_number] => 20220145353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Sensitive glucose assay
[patent_app_type] => utility
[patent_app_number] => 17/348748
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348748
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348748 | Sensitive glucose assay | Jun 14, 2021 | Abandoned |
Array
(
[id] => 18468816
[patent_doc_number] => 20230203098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/801261
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801261 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | Feb 21, 2021 | Pending |
Array
(
[id] => 18468816
[patent_doc_number] => 20230203098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/801261
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801261 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | Feb 21, 2021 | Pending |
Array
(
[id] => 17595697
[patent_doc_number] => 20220145271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Enzyme with acyl transfer function and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/432099
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432099 | Enzyme with acyl transfer function and application thereof | Dec 6, 2020 | Issued |
Array
(
[id] => 19002036
[patent_doc_number] => 20240066107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => PHARMACEUTICAL COMPOSITION AND KIT FOR TREATING GOUT
[patent_app_type] => utility
[patent_app_number] => 16/996846
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996846
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996846 | Pharmaceutical composition and kit for treating gout | Aug 17, 2020 | Issued |
Array
(
[id] => 18211323
[patent_doc_number] => 20230057586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => OPTIMIZED CULTURE MEDIA FOR CLOSTRIDIA BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/633996
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633996
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633996 | OPTIMIZED CULTURE MEDIA FOR CLOSTRIDIA BACTERIA | Jul 20, 2020 | Abandoned |
Array
(
[id] => 17990462
[patent_doc_number] => 20220356499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => ENDOGLUCANASE, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/621992
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17621992
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/621992 | ENDOGLUCANASE, AND USE THEREOF | Jul 19, 2020 | Abandoned |
Array
(
[id] => 19326192
[patent_doc_number] => 12043859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Recovery, decarboxylation, and purification of cannabinoids from engineered cell cultures
[patent_app_type] => utility
[patent_app_number] => 17/426973
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13207
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426973 | Recovery, decarboxylation, and purification of cannabinoids from engineered cell cultures | Jan 29, 2020 | Issued |
Array
(
[id] => 17685913
[patent_doc_number] => 20220193205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHODS OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/420296
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420296 | METHODS OF TREATING CANCER | Jan 6, 2020 | Abandoned |
Array
(
[id] => 17383964
[patent_doc_number] => 20220031816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/299682
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299682
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/299682 | CANCER TREATMENT | Dec 5, 2019 | Abandoned |
Array
(
[id] => 15927843
[patent_doc_number] => 20200155555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => VITAMIN RECEPTOR DRUG DELIVERY CONJUGATES FOR TREATING INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/682200
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16682200
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/682200 | VITAMIN RECEPTOR DRUG DELIVERY CONJUGATES FOR TREATING INFLAMMATION | Nov 12, 2019 | Abandoned |
Array
(
[id] => 17343648
[patent_doc_number] => 20220009979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT DYSREGULATION USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/267308
[patent_app_country] => US
[patent_app_date] => 2019-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267308
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267308 | FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT DYSREGULATION USING THE SAME | Aug 21, 2019 | Abandoned |
Array
(
[id] => 17038248
[patent_doc_number] => 20210255207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => BIOMARKERS FOR COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 17/056066
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056066 | BIOMARKERS FOR COLORECTAL CANCER | May 22, 2019 | Abandoned |